Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, E.
Right arrow Articles by Tsurushita, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, E.
Right arrow Articles by Tsurushita, N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Antibodies cross-reactive with E- and P-selectin block both E- and P- selectin functions

EL Berg, C Fromm, J Melrose and N Tsurushita

Protein Design Labs, Inc. Mountain View, CA 94043.

E- and P-selectin are inflammation-induced cell adhesion molecules that mediate leukocyte-endothelial cell and leukocyte-platelet interactions. Monoclonal antibodies (MoAbs) specific for either E-selectin or P- selectin are protective in several animal models of inflammatory disease. To generate an MoAb with broader therapeutic potential, MoAbs that bind to both E- and P-selectin were generated by immunization of mice with mouse pre-B cell lines transfected with human E- and P- selectin. Interestingly, although the only selection criterion was the ability to bind both E- and P-selectin, all three antibodies obtained efficiently block both E- and P-selectin-mediated functions. The inhibited functions include neutrophil or HL-60 cell binding to tumor necrosis factor-alpha-activated human umbilical vein endothelial cells, E- or P-selectin transfectant cell lines, and platelet-HL-60 rosetting. These antibodies, EP-5C7, EP-2C9, and EP-1D8, recognize the same or overlapping epitope within the lectin domains of E- and P-selectin. The data suggest that functionally important epitopes of homologous proteins can be targeted by selecting for antibodies with reactivity toward both proteins. Furthermore, a potent blocking antibody specific for both E- and P-selectin may provide a more effective and broadly useful reagent for treating acute and potentially certain chronic inflammatory conditions.

Volume 85, Issue 1, pp. 31-37, 01/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
V. Bhaskar, D. A. Law, E. Ibsen, D. Breinberg, K. M. Cass, R. B. DuBridge, F. Evangelista, S. M. Henshall, P. Hevezi, J. C. Miller, et al.
E-Selectin Up-Regulation Allows for Targeted Drug Delivery in Prostate Cancer
Cancer Res., October 1, 2003; 63(19): 6387 - 6394.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Mocco, T. Choudhri, J. Huang, E. Harfeldt, L. Efros, C. Klingbeil, V. Vexler, W. Hall, Y. Zhang, W. Mack, et al.
HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke
Circ. Res., November 15, 2002; 91(10): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. I. Simon, Y. Hu, D. Vestweber, and C. W. Smith
Neutrophil Tethering on E-Selectin Activates {beta}2 Integrin Binding to ICAM-1 Through a Mitogen-Activated Protein Kinase Signal Transduction Pathway
J. Immunol., April 15, 2000; 164(8): 4348 - 4358.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. J. Fredrickson, N. A. Turner, N. S. Kleiman, N. Graziadei, K. Maresh, M. A. Mascelli, M. B. Effron, and L. V. McIntire
Effects of Abciximab, Ticlopidine, and Combined Abciximab/Ticlopidine Therapy on Platelet and Leukocyte Function in Patients Undergoing Coronary Angioplasty
Circulation, March 14, 2000; 101(10): 1122 - 1129.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Melrose, N. Tsurushita, G. Liu, and E. L. Berg
IFN-{gamma} Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells
J. Immunol., September 1, 1998; 161(5): 2457 - 2464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Y. He, Z. Xu, J. Melrose, A. Mullowney, M. Vasquez, C. Queen, V. Vexler, C. Klingbeil, M. S. Co, and E. L. Berg
Humanization and Pharmacokinetics of a Monoclonal Antibody with Specificity for Both E- and P-Selectin
J. Immunol., January 15, 1998; 160(2): 1029 - 1035.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. M. McEvoy, M. A. Jutila, P. S. Tsao, J. P. Cooke, and E. C. Butcher
Anti-CD43 Inhibits Monocyte-Endothelial Adhesion in Inflammation and Atherogenesis
Blood, November 1, 1997; 90(9): 3587 - 3594.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H.-P. Haring, E. L. Berg, N. Tsurushita, M. Tagaya, G. J. del Zoppo, and M. J Eppihimer
E-Selectin Appears in Nonischemic Tissue During Experimental Focal Cerebral Ischemia
Stroke, August 1, 1996; 27(8): 1386 - 1392.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020